Novartis traded at $91.30 this Wednesday May 25th, decreasing $0.64 or 0.69 percent since the previous trading session. Looking back, over the last four weeks, Novartis lost 0.95 percent. Over the last 12 months, its price rose by 3.18 percent. Looking ahead, we forecast Novartis to be priced at 86.34 by the end of this quarter and at 80.34 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
91.30
Daily Change
-0.69%
Yearly
3.18%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 151.98 2.86 1.92% 32.50%
Amgen 252.76 0.87 0.35% 5.96%
AstraZeneca 10,554.00 -44.00 -0.42% 31.60%
Astrazeneca 66.58 -0.07 -0.11% 16.99%
Biogen 202.08 -0.46 -0.23% -24.55%
Bristol-Myers Squibb 77.25 0.12 0.15% 16.81%
Corcept Therapeutics 19.95 -0.05 -0.25% -5.67%
Catalent 96.69 -0.07 -0.07% -7.29%
Endo International 0.40 0.04 9.70% -92.83%
Gilead Sciences 64.99 0.64 0.99% -2.06%
GlaxoSmithKline 1,780.40 -1.60 -0.09% 31.57%
Glaxosmithkline 44.88 -0.12 -0.27% 16.09%
Horizon Pharma 88.43 0.40 0.45% -5.62%
Jazz Pharmaceuticals 145.47 2.49 1.74% -18.14%
J&J 179.27 -2.13 -1.17% 6.03%
Lannett 0.51 0 0% -89.46%
Eli Lilly 307.02 1.06 0.35% 52.75%
Merck & Co 93.74 -0.91 -0.96% 21.37%
Phibro Animal Health 18.28 -0.22 -1.19% -33.70%
Prestige Brands 55.86 0.22 0.40% 13.51%
Pacira 60.99 0.34 0.55% -8.16%
Pfizer 53.72 0.31 0.58% 38.03%
Powershares High Yield Orate Bond Portfolio 17.59 0.07 0.37% -9.17%
Perrigo 39.21 0.69 1.79% -16.09%
Drreddys Laboratories 55.78 -0.70 -1.24% -23.33%
Roche Holding 332.60 1.15 0.35% 6.50%
Sanofi 103.86 0.24 0.23% 17.14%
Sanofi 55.77 -0.52 -0.92% 3.84%
Supernus Pharmaceuticals 27.11 0.13 0.48% -9.36%
Teva Pharmaceutical Industries 8.53 0.08 0.95% -18.61%
United States Oil Fund 81.90 -0.10 -0.12% 81.19%
Bausch Health Companies Inc 12.25 0.35 2.94% -67.52%
Canopy Growth Corp 6.45 0.39 6.44% -77.87%
Zoetis 163.18 0.13 0.08% -7.61%


Novartis
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.